Seikagaku (TSE:4548) ROCE % : 3.91% (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Seikagaku ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Seikagaku's annualized ROCE % for the quarter that ended in Dec. 2023 was 3.91%.

Seikagaku ROCE % Historical Data

The historical data trend for Seikagaku's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seikagaku ROCE % Chart

Seikagaku Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

3.81

-13.93

4.82

8.19

4.50

Seikagaku Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															3.48	-6.55	11.15	2.03	3.91

Seikagaku ROCE % Calculation

Seikagaku's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	3074	/	( ( (75244 - 7533)	+	(75625 - 6699) )	/ 2 )
	=	3074	/	( (67711	+	68926)	/ 2 )
	=	3074	/	68318.5
	=	4.50 %

Seikagaku's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	2892	/	( ( (79620 - 5808)	+	(79886 - 5932) )	/ 2 )
	=	2892	/	( ( 73812	+	73954 )	/ 2 )
	=	2892	/	73883
	=	3.91 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Seikagaku (TSE:4548) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Seikagaku ROCE % Related Terms

Thank you for viewing the detailed overview of Seikagaku's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Seikagaku (TSE:4548) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Seikagaku Corp (TSE:4548) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Marunouchi Center Building 10 Floor, 6-1, Marunouchi 1-chome, Chiyoda-ku, Tokyo, JPN, 100-0005

Website

http://www.seikagaku.co.jp

Seikagaku Corp makes and sells pharmaceuticals and medical devices related to glycoconjugates. The firm operates in two segments: pharmaceutical and LAL. The pharmaceutical segment contributes the majority of revenue. This business sells pharmaceutical products made from hyaluronic acid, a major component of glycoconjugates, as well as medical devices and bulk products. The LAL segment manufactures endotoxin-detecting reagents made from limulus amebocyte lysate that are used to control quality in the pharmaceutical manufacturing process. Seikagaku generates the majority of its sales in Japan.

Seikagaku (TSE:4548) Headlines

No Headlines